Gene: KRAS ×
Source: BEFREE ×
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.070 AlteredExpression disease BEFREE Cetuximab is widely used in patients with metastatic colon cancer expressing wildtype KRAS. 29160412 2017
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.070 GeneticVariation disease BEFREE Using Naïve Bayesian Analysis to Determine Imaging Characteristics of KRAS Mutations in Metastatic Colon Cancer. 28869500 2017
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.070 GeneticVariation disease BEFREE A total of 121 patients with KRAS exon 2 codon 12/13 wild-type metastatic colon cancer were enrolled between January 2007 and December 2013. 26935130 2016
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.070 GeneticVariation disease BEFREE KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer. 27062566 2016
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.070 Biomarker disease BEFREE Herein we report a case of metastatic colon cancer with conflicting testing results for the KRAS oncogene from two different reference laboratories. 23792572 2013
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.070 GeneticVariation disease BEFREE The type of K-RAS mutation or amino acid changes may have prognostic implications in metastatic colon cancer patients. 22791568 2012
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.070 Biomarker disease BEFREE Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer. 19884556 2009